Dr. Stefanie Senger studied statistics at the University of Dortmund and received her PhD in Bioinformatics from the Free University of Berlin, Germany in 2006. She worked at the Max Planck Institute for Molecular Genetics in Berlin with focus on statistical approaches in computational biology and was employed as Principal Biostatistician at Merck KGaA (EMD Serono), where she gained experience in the planning, conduct and statistical analysis of Phase I-III clinical trials. Dr. Senger is currently employed as Senior Principal Biostatistician at Momentum Research, Inc., and has co-authored over 20 scientific articles in the fields of bioinformatics, oncology and heart failure.